Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl ] piperazine

Details for Australian Patent Application No. 2010238946 (hide)

Owner H. Lundbeck A/S

Inventors Treppendahl, Svend; Lopez De Diego, Heidi

Agent Spruson & Ferguson

Pub. Number AU-A-2010238946

PCT Pub. Number WO2010/121621

Priority PA 200900531 24.04.09 DK

Filing date 16 April 2010

Wipo publication date 28 October 2010

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 December 2011 Amendment Made

  The nature of the amendment is: Amend the priority details to read PA 200900531 24 Apr 2009 DK 2010239266 Resverlogix Corp. The nature of the amendment is as shown in the statement(s) filed 31 Oct 2011

8 December 2011 PCT application entered the National Phase

  PCT publication WO2010/121621 Priority application(s): WO2010/121621

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010238985-Novel 7-deazapurine nucleosides for therapeutic uses

2010238945-Particulate material for controlled release of active ingredients